research Correlation of Trichoscopic Findings with Disease Severity in Androgenetic Alopecia
Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.
Search
for
Sort by
Research
30-60 / 1000+ results
research Platelet-rich plasma microneedling versus 5% topical minoxidil in the treatment of patterned hair loss
Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.
research Clinical use of 5α-reductase inhibitors
Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.
research Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation
10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.
research 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY
Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.
research Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.
research Approach to hair transplantation in advanced grade baldness by follicular unit extraction: A retrospective analysis of 820 cases
Follicular unit extraction is an effective hair transplant method for advanced baldness with high patient satisfaction, but some experienced decreased density over time.
research Prevalence Of Male Balding Pattern In Patient From Saveetha Dental College- Retrospective Comparative Evaluation Study
Balding in men worsens with age.
research Characterization of the Safe Donor Area in the Indian Population Aged 50-55 Years
Most Indian men aged 50-55 have a safe area for hair transplants, but selection should be careful to avoid overharvesting.
research A Study on Optimal Frequency and Duration of PRP in Androgenic Alopecia
PRP therapy significantly improves hair thickness and density in male pattern baldness.
research Assessment of Efficacy and Safety Profile of Platelet Rich Plasma (PRP) Therapy with Derma Roller in the Treatment of Female Pattern Hair Loss
PRP therapy with a derma roller is a safe and effective treatment for female hair loss.
research Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.
research Androgenetic alopecia
Hair loss from genetics and hormones can be treated with drugs or surgery.
research Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
Androgenetic alopecia may increase the severity of COVID-19.
research A study of patterns of androgenetic alopecia in men: an Indian perspective
Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.
research O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
Low-dose oral minoxidil and finasteride effectively improve hair growth in men with androgenetic alopecia.
research Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia
No link found between hair loss severity and PSA levels in men.
research Efficacy of Oral Minoxidil in the Treatment of Androgenic Alopecia in Male Patients Presenting at a Tertiary Care Hospital
Oral Minoxidil effectively treats male pattern baldness.
research Clinical and metabolic characteristics of males with early-onset androgenetic alopecia.
Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.
research Assessment of efficacy of different botulinum toxin A concentrations in the treatment of androgenetic alopecia assessed by dermoscopy
Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.
research The type of androgenetic alopecia and quality of life (QoL) in male patients
More severe hair loss worsens quality of life in men.
research An observational study of the association between androgenetic alopecia and size of the prostate
The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.
research Male androgenetic alopecia: Population-based study in 1,005 subjects
58% of men aged 30-50 have hair loss, with severity increasing with age.
research HairLossMultinet: A Multi Scale Feature Fusion Method Using Deep Learning Approach
HairLossMultinet accurately classifies hair damage with 98% accuracy but needs a more diverse dataset for broader use.
research One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
There is no link between hair loss and prostate enlargement.
research Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.
research Gravity position to prevent facial edema in hair transplantation
Keeping the head elevated for 1.5 days after hair transplant surgery helps prevent facial swelling.
research Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.
research Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
Men with enlarged prostates often have more severe baldness.
research Alopecia in patients treated with molecularly targeted anticancer therapies
Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.